Showing results (51-60 of 75) with videos related to
Sort By:
Pageof 8
European Journal of Cancer (Oxford, England : 1990)|April 10, 2024
Prognostic and predictive impact of sex in locally advanced microsatellite instability high gastric or gastroesophageal junction cancer: An individual patient data pooled analysis of randomized clinical trialsAlessandra Raimondi, Young Woo Kim, Won Ki Kang, et al.European Journal of Cancer (Oxford, England : 1990)|October 1, 2022
Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clustersMargherita Rimini, Eleonora Loi, Carles Fabregat-Franco, et al.Cancer Medicine|December 2, 2024
Molecular Characterization and Clinical Relevance of MGMT-Silenced Pancreatic CancerFederico Nichetti, Marco Silvestri, Luca Agnelli, et al.International Journal of Cancer|June 20, 2022
Platinum sensitivity in patients with IDH1/2 mutated vs wild-type intrahepatic cholangiocarcinoma: A propensity score-based studyMonica Niger, Federico Nichetti, Andrea Casadei-Gardini, et al.Journal of Gastrointestinal Cancer|February 5, 2021
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS IndexGiulia Rovesti, Francesco Leone, Giovanni Brandi, et al.Therapeutic Advances in Medical Oncology|August 4, 2022
Efficacy of mRNA anti-SARS-CoV-2 vaccination and dynamics of humoral immune response in patients with solid tumors: results from the institutional registry of an Italian tertiary cancer centerGiovanni Fucà, Mara Lecchi, Chiara Maura Ciniselli, et al.The Oncologist|March 19, 2026
Second-line chemotherapy after gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer: comparative outcomes and AI-guided treatment selectionLetizia Procaccio, Guido Giordano, Federico Nichetti, et al.Lung Cancer (Amsterdam, Netherlands)|May 18, 2019
Oral maintenance metronomic vinorelbine versus best supportive care in advanced non-small-cell lung cancer after platinum-based chemotherapy: The MA.NI.LA. multicenter, randomized, controlled, phase II trialMarco Platania, Felice Pasini, Luca Porcu, et al.JCO Precision Oncology|July 24, 2023
Molecular Tumor Board as a Clinical Tool for Converting Molecular Data Into Real-World Patient CareAndrea Vingiani, Luca Agnelli, Matteo Duca, et al.Liver International : Official Journal of the International Association for the Study of the Liver|August 21, 2024
Lymphotoxin beta-activated LTBR/NIK/RELB axis drives proliferation in cholangiocarcinomaKaiyu Xu, Annika Kessler, Federico Nichetti, et al.Pageof 8